Literature DB >> 943818

Inhibition of drug metabolism by fluoxetine.

R W Fuller, R C Rathbun, C J Parli.   

Abstract

Fluoxetine hydrochloride (Lilly 110140: 3-p-trifluoromethylphenoxy-3-phenyl-N-methyl-propylamine hydrochloride) inhibited the metabolism of hexobarbital and ethinamate in rodents and prolonged the hypnotic effects of these drugs.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 943818

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


  7 in total

1.  Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports.

Authors:  P Jalil
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

2.  Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

Authors:  T A Lasher; J C Fleishaker; R C Steenwyk; E J Antal
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Fluoxetine enhances memory processing in mice.

Authors:  J F Flood; A Cherkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  On the role of 5-hydroxytryptamine in drug-induced antinociception.

Authors:  M F Sugrue
Journal:  Br J Pharmacol       Date:  1979-04       Impact factor: 8.739

5.  Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat.

Authors:  S Caccia; M Cappi; C Fracasso; S Garattini
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 6.  Use of psychotropic drugs in patients with HIV infection.

Authors:  J L Ayuso
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 7.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; R C Heel; S P Lewis
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.